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Abstracts / Urological Science 26 (2015) S50eS81 S77male smoker in our study. This result may encourage the smoking men to
stop smoking to enhance their erectile function.
NDP103:
MANAGEMENT OF ERECTILE DYSFUNCTION IN PATIENTS WHO FAILED
PRIOR VASCULAR INTERVENTION
Cheng-Hsing Hsieh 1, Geng-Long Hsu 2,3, Shyh-Chyan Chen 3, Chih-Yuan
Hsu 2. 1Division of Urology, Taipei Tzu Chi Hospital, The Buddhist Tzuchi
Medical Foundation; School of Medicine, Buddhist Tzu-Chi University,
Hualien, Taiwan; 2Microsurgical Potency Reconstruction and Research
Center, Hsu's Andrology, Taipei, Taiwan; 3Department of Urology, National
Taiwan University Hospital, College of Medicine, Taipei, Taiwan
Purpose: Varied penile vascular interventions are still controversial and
commonly regarded as experimental settings. Disappointing outcome and
penile dysmorphology are major concerns along with other complications.
To explode whether our penile venous stripping can salvage other
methods of vascular treatment, we report our experience.
Materials and Methods: From 2010 to 2014, 11consecutive patients
sought our assistance owing to disappointing prior vascular in-
terventions elsewhere. The abridged ﬁve-item version of the Interna-
tional Index of Erectile Function (IIEF-5) was used to score the patients. A
circumferential incision was ﬁrst made to access the deep dorsal veins
and cavernosal veins which were stripped thoroughly and ligated with 6-
0 nylon sutures. A median longitudinal pubic incision was used to com-
plete the stripping proximally and the para-arterial veins were just
ligated segmentally. Finally the wound was fashioned layer by layer with
5-0 chromic suture.
Results: The operation time was from 4.0 to 8.5 hours. The follow-up
period ranged from 0.6-4.0 years. Overall all patients reported satisfactory
penile morphology postoperatively while the preoperative and post-
operative IIEF-5 scores was signiﬁcant difference (8.8± 2.6 vs.16.6± 2.8,
P < 0.001).
Conclusion: This series of salvaging venous surgeries, though technically
challenging, was exclusively beneﬁcial and appeared a viable option to
patients who had undergone prior vascular interventions.
NDP104:
EVALUATION OF PENILE BLOOD FLOW INCLUDING PEAK SYSTOLIC
VELOCITY, END DIASTOLIC VELOCITY AND RIGIDITY INDEX: FIVE
PATIENTS OF ERECTILE DYSFUNCTION EXPERIENCE IN SHIN KONG
MEMORIAL HOSPITAL IN ONE YEAR
Chao Wei Tseng, Thomas I.S. Hwang. Division of Urology, Department of
Surgery, Shin Kong WHS Memorial Hospital, Taipei, Taiwan
Purpose: Erectile dysfunction is very common at the age of above 40s. The
previous studies from Taiwan revealed around 50% male had ED problem
once before. The psychological or physiological aspects both inﬂuence
pathway of tumecence and rigidity. Most of the patients had a lot of
improvement from PDE5 inhibitors, such as Viagra, Cialis, Levitra. It seems
that carvernosal artery plays a key role of tumecence. We evaluate the
patients with ED who had examined peak systolic velocity (PSV) and end
diastolic velocity (EDV).
Materials and Methods: We review charts from patients of erectile
dysfunctionwho had examined his penile blood ﬂow status including PSV/
EDV/RI. We also record his testosterone level, triglyceride and total
cholesterol.
Results: We had investigated ﬁve patients. The age ranges from 24 to 70
years old. The testosterone level ranges from 3.4ng/ml to 6.6ng/ml (1.75ng/
ml~7.81ng/ml).
Peak systolic velocity after alprostadilintracoporeal injection range from
11.39ml/sec to 21.82ml/sec.
Conclusion: The penile blood ﬂow from Doppler ultrasound is a very
useful tool for evaluating erectile dysfunction.We think that penile blood
ﬂow evaluation as a routine examination for patient of erectile dysfunc-
tion.Female Urology & Urodynamics
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Purpose: Endometrial cancer (EC) is fatal with rising incidence and mor-
tality. Pelvic inﬂammatory disease (PID), a common gynecologic disease,
had been connected to EC, but the evidence was scarce. We aimed to
investigate the association between PID and EC.
Materials and Methods: We constituted a nationwide population-based
cohort study and data were obtained from the National Health Insurance
Research Database (NHIRD).We deﬁned 41065 patients with PID as the PID
group, and 82130 randomly selected patients as the comparison group
through frequency matching by age and index year. Diagnosis of related
diseases was conducted according to the International Classiﬁcation of
Diseases, Ninth Revision, Clinical Modiﬁcation (ICD-9-CM). Each patient
was individually tracked to identify those who developed EC. Cox pro-
portional hazards regression and the Kaplan-Meier method were used in
the analysis.
Results: Overall, the incidence rate of 9.6 and 16.1 per 100000 person-
year and mean follow-up duration of 4.84 and 6.63 years were observed
among patients in the PID and non-PID cohorts, respectively. After
adjusting for potential risk factors, PID women were observed to have a
1.78-fold higher risk of developing endometrial cancer compared with the
non-PID cohort. Consideration for other potential risk factors, the inci-
dence of EC increased with ageing, particular for those aged over 50 years
(HR ¼ 2.44, 95% CI ¼ 1.28-4.63). In addition, for women with hyperten-
sion, the increased EC risk was also shown in PID patients compared to
non-PID cohort.
Conclusion: In the large-scale population-based study, we indicated
the increased EC risk in PID patients, particular for patients with older
age or those with hypertension. Future, large-scale clinical trial would be
required to clarify the role of medication played in PID-related EC progress.
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Purpose: Long term ketamine abuse may cause variable lower urinary
tract symptoms (LUTS) and severe cystitis. The clinical features of keta-
mine associated cystitis (KC) are very similar to bladder pain syndrome/
interstitial cystitis (BPS/IC). Intravesical administration of hyaluronic acid
(HA) is one of the regimens for treating BPS/IC. In this study, we aim to
investigate whet her intravesical HA therapy may improve the LUTS of
patients with KC.
Materials and Methods: 4 female and 1 male patients with KC who failed
oral medications were enrolled in this study. Hyaluronic acid (Cystistat®)
at a dose of 40 mg in a volume of 50 ml of phosphate-buffered saline was
injected into the bladder on a weekly basis for 6 weeks and then monthly
for a further 3 months. Response to therapy was evaluated by Visual
Analogue Scale for pain (VAS), International Prostate Symptom Score
